KCT0009026已完成未知
A 8-week randomized, double-blind, placebo-controlled trial to improve intestinal health (constipation and gut microbiota)
Ildong Bioscience0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 65(Year)（—）
- 性别
- All
入选标准
- •Adult men and women between the ages of 19 and 65
- •- If you have hard or lumpy stools more than 1 time out of 4, or soft stools less than 1 time out of 4 according to Rome IV standards.
排除标准
- •- Those diagnosed with constipation other than constipation-type irritable bowel syndrome
- •- Those with a history of gastrointestinal surgery (excluding appendectomy and cesarean section)
- •- If there are warning symptoms such as rectal bleeding or weight loss
- •- If you currently have a disease that may affect the evaluation of drug efficacy in the digestive system (e.g., organic disease such as colitis, colon cancer, etc.) or have had it within the past 2 years
- •- Probiotics, prebiotics, synbiotics, antibiotics, corticosteroids, antidepressants, antihistamines, non-steroidal anti-inflammatory drugs, and other drugs that affect intestinal motility (laxatives, antidiarrheals, intestinal motility stimulants, and antispasmodics) within the previous 2 weeks. Those who took it
- •- If you have concomitant diseases such as liver cancer or cirrhosis, chronic renal failure, congestive heart failure, or thyroid disease
- •- Pregnant women, lactating women, and women of childbearing potential who plan to become pregnant or breast-feed during the participation period.
- •- Patients with mental illnesses such as depression, schizophrenia, alcoholism, drug addiction, etc.
- •- Those who have hypersensitivity to the test product or ingredients contained in the test product or are allergic to a specific ingredient
- •- Those who participated in another clinical trial within the last 3 months
- •- Subjects who, in the opinion of the researcher, are judged to be unable to comply with the test requirements or are otherwise deemed unsuitable by the doctor.
研究者
相似试验
招募中
不适用
An 8-week, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of probiotics NVP-1704 on sleep improvementMental and behavioural disordersKCT0009096Seoul National University Bundang Hospital120
已完成
Unknown
Human study of Theracurmin for verification of anti-oxidant effectKCT0008731Seoul National University120
已完成
不适用
Human study to evaluate efficacy and safety of red balloon flower root extract on enhancement of immune functioKCT0005945Gachon University100
已完成
不适用
An 8-week, randomized, double-blinded, placebo-controlled clinical trial to evaluate the efficacy and safety of Lactobacillus plantarum HAC01 on the postprandial glucose levels.KCT0005652AtoGen40
招募中
不适用
A 8-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Saccaharum Officinalis wax alcohols(Policosanol) on improvement of blood cholesterolKCT0006606Wonkwang University. Iksan Korean Medicine Hospital80